[{"id":"4acb6abb-0e75-40d3-b1ae-c75f3c08ab49","acronym":"TACTIC-19","url":"https://clinicaltrials.gov/study/NCT03880279","created_at":"2021-01-18T19:07:45.129Z","updated_at":"2024-07-02T16:36:16.781Z","phase":"Phase 1/2","brief_title":"Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma","source_id_and_acronym":"NCT03880279 - TACTIC-19","lead_sponsor":"Triumvira Immunologics, Inc.","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" BCL6 rearrangement • BCL2 rearrangement","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TAC01-CD19"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 05/01/2020","start_date":" 05/01/2020","primary_txt":" Primary completion: 04/01/2022","primary_completion_date":" 04/01/2022","study_txt":" Completion: 04/01/2024","study_completion_date":" 04/01/2024","last_update_posted":"2022-02-23"}]